114 related articles for article (PubMed ID: 37527640)
21. Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection.
Do SK; Choi SH; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Lee EB; Shin KM; Jeong JY; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Seok Y; Cho S; Jheon S; Park JY
Gene; 2019 Jun; 703():58-64. PubMed ID: 30954677
[TBL] [Abstract][Full Text] [Related]
22. PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade.
Yoshida H; Nomizo T; Ozasa H; Tsuji T; Funazo T; Yasuda Y; Ajimizu H; Yamazoe M; Kuninaga K; Ogimoto T; Hosoya K; Itotani R; Sakamori Y; Kim YH; Hirai T
Eur J Cancer; 2021 Feb; 144():317-325. PubMed ID: 33385948
[TBL] [Abstract][Full Text] [Related]
23. [A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].
Zhou J; Ma Q; Guo C; Shi L; Yao Y; Yu J; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):909-14. PubMed ID: 25609128
[TBL] [Abstract][Full Text] [Related]
24. Intronic variant of EGFR is associated with GBAS expression and survival outcome of early-stage non-small cell lung cancer.
Hong MJ; Lee SY; Choi JE; Kang HG; Do SK; Lee JH; Yoo SS; Lee EB; Seok Y; Cho S; Jheon S; Lee J; Cha SI; Kim CH; Park JY
Thorac Cancer; 2018 Aug; 9(8):916-923. PubMed ID: 29806744
[TBL] [Abstract][Full Text] [Related]
25. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
28. RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer.
Choi YY; Lee SY; Lee WK; Jeon HS; Lee EB; Lee HC; Choi JE; Kang HG; Lee EJ; Bae EY; Yoo SS; Lee J; Cha SI; Kim CH; Kim IS; Lee MH; Kim YT; Jheon S; Park JY
Oncotarget; 2015 Feb; 6(6):4451-66. PubMed ID: 25686824
[TBL] [Abstract][Full Text] [Related]
29. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Liao Z; Ma H; Qian J; Liu Z; Yuan X; Gomez D; Komaki R; Wang LE; Wei Q
BMC Cancer; 2011 Oct; 11():447. PubMed ID: 21995493
[TBL] [Abstract][Full Text] [Related]
30. Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Do SK; Jeong JY; Lee SY; Choi JE; Hong MJ; Kang HG; Lee WK; Seok Y; Lee EB; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Neugent ML; Goodwin J; Kim JW; Park JY
Ann Surg Oncol; 2018 Oct; 25(11):3396-3403. PubMed ID: 30062472
[TBL] [Abstract][Full Text] [Related]
31. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
32. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
[TBL] [Abstract][Full Text] [Related]
33. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
[TBL] [Abstract][Full Text] [Related]
34. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
35. Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.
Qian J; Gu S; Wu Q; Zhao X; Wu W; Gao Z; Zhang W; Tan X; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
Chest; 2012 Sep; 142(3):680-689. PubMed ID: 22441531
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.
Liu B; Liu Q; Song Y; Li X; Wang Y; Wan S; Zhang Z; Su H
Med Oncol; 2014 Apr; 31(4):877. PubMed ID: 24567056
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese.
Ma H; Shu Y; Pan S; Chen J; Dai J; Jin G; Hu Z; Shen H
Lung Cancer; 2011 Nov; 74(2):164-9. PubMed ID: 21514686
[TBL] [Abstract][Full Text] [Related]
39. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
Kim MJ; Kang HG; Lee SY; Jeon HS; Lee WK; Park JY; Lee EB; Lee JH; Cha SI; Kim DS; Kim CH; Kam S; Jung TH; Park JY
J Surg Oncol; 2012 Feb; 105(2):167-74. PubMed ID: 21842521
[TBL] [Abstract][Full Text] [Related]
40. Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer.
Pineda Lancheros LE; Pérez Ramírez C; Sánchez Martín A; Gálvez Navas JM; Martínez Martínez F; Ramírez Tortosa MDC; Jiménez Morales A
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
